Lite Strategy (LITS) Intangibles (2012 - 2020)
Lite Strategy (LITS) posted quarterly Intangibles of $235000.0 for Q1 2020, down 12.96% year-over-year from $270000.0 in Q2 2019, and down 3.69% quarter-over-quarter from $244000.0 in Q4 2019.
Lite Strategy (LITS) Intangibles (2012 - 2020) Analysis & Trends
Lite Strategy's Intangibles history runs 9 years deep, the most recent figure standing at $235000.0 for Q1 2020.
- In Q1 2020, Intangibles fell 12.96% year-over-year to $235000.0; the TTM figure through Mar 2020 stood at $235000.0 (down 12.96% YoY), while the FY2019 annual figure was $261000.0, down 11.82% from the prior year.
- Intangibles for Q1 2020 stood at $235000.0, down from $244000.0 in the prior quarter.
- The five-year high for Intangibles was $374000.0 in Q1 2016, with the low at $235000.0 in Q1 2020.
- The 5-year median for Intangibles is $305000.0 (2018), against an average of $304823.5.
- The sharpest annual moves came in 2016 and 2020: Intangibles decreased 8.56% in 2016, then fell 12.96% in 2020.
- Lite Strategy's Intangibles stood at $348000.0 in 2016, then retreated by 9.77% to $314000.0 in 2017, then declined by 11.15% to $279000.0 in 2018, then decreased by 12.54% to $244000.0 in 2019, then retreated by 3.69% to $235000.0 in 2020.
- Business Quant data shows LITS's Intangibles at $235000.0 in Q1 2020, $244000.0 in Q4 2019, and $253000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - | 40.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 235,000.00 |
| Dec 31, 2019 | 244,000.00 |
| Sep 30, 2019 | 253,000.00 |
| Jun 30, 2019 | 261,000.00 |
| Mar 31, 2019 | 270,000.00 |
| Dec 31, 2018 | 279,000.00 |
| Sep 30, 2018 | 287,000.00 |
| Jun 30, 2018 | 296,000.00 |
| Mar 31, 2018 | 305,000.00 |
| Dec 31, 2017 | 314,000.00 |
| Sep 30, 2017 | 322,000.00 |
| Jun 30, 2017 | 331,000.00 |
| Mar 31, 2017 | 340,000.00 |
| Dec 31, 2016 | 348,000.00 |
| Sep 30, 2016 | 357,000.00 |
| Jun 30, 2016 | 366,000.00 |
| Mar 31, 2016 | 374,000.00 |
| Dec 31, 2015 | 383,000.00 |
| Sep 30, 2015 | 392,000.00 |
| Jun 30, 2015 | 401,000.00 |